Publications by authors named "Marc Pineton De Chambrun"

Background: Millions of households have cats or dogs as pets, and infections due to bites or scratches are increasing, with the most common pathogens being spp., spp., spp, and .

View Article and Find Full Text PDF

BackgroundAssessment of contemporary cardiovascular risk scores using clinically relevant endpoints is lacking in systemic lupus erythematosus (SLE).AimThis study aimed to assess and compare the performances of SCORE2, QRISK3 and PREVENT equations in SLE.MethodsSLE patients with no prior atherosclerotic cardiovascular disease (ASCVD) who underwent a baseline cardiovascular risk assessment including coronary artery calcium (CAC) scoring at the French national SLE reference center between 2014 and 2024 were retrospectively included.

View Article and Find Full Text PDF

Background: Monoclonal gammopathy-associated capillary leak syndrome (MG-CLS) is a rare condition characterized by recurrent episodes of hypovolemic shock caused by a sudden increase in capillary permeability. The COVID-19 pandemic has been associated with a rise in MG-CLS episodes and increased mortality. We aimed to explore the association between MG-CLS and SARS-CoV-2 infection.

View Article and Find Full Text PDF

Rationale: The significance of the Recruitment to Inflation (R/I) ratio in identifying PEEP recruiters in patients undergoing ultra-protective lung ventilation during venovenous ECMO is not well established.

Objectives: To compare the concordance of the R/I ratio and Electrical Impedance Tomography (EIT) in determining optimum PEEP settings in severe ARDS patients on ECMO and ventilated with very low tidal volumes.

Methods: Initially, a low-flow insufflation was performed to detect and measure the airway opening pressure (AOP).

View Article and Find Full Text PDF

Introduction: Human Herpesvirus-6 (HHV-6) DNAemia is not rare in intensive care unit (ICU) patients. However, evidence for a causal association of HHV-6 DNAemia with organ disease and with mortality is limited in this setting. In ICU patients with HHV-6 DNAemia, we sought to 1) assess the prevalence of HHV-6 disease, 2) identify risk factors for HHV-6 disease and 3) investigate its association with mortality.

View Article and Find Full Text PDF

Objective: Antiphospholipid syndrome (APS) is an acquired autoimmune prothrombotic condition. Vascular liver disorders (VLD), such as portal vein thrombosis (PVT), Budd-Chiari syndrome (BCS) and porto-sinusoidal vascular disorder (PSVD), are rare and related to an underlying hypercoagulable state in most cases. We aimed to describe the clinical and immunological features of APS patients with VLD.

View Article and Find Full Text PDF

Background: Preliminary evidence from small, single-center studies suggests levosimendan may improve the likelihood of successful venoarterial extracorporeal membrane oxygenation (VA-ECMO) weaning in patients with cardiogenic shock. However, the literature is limited and presents conflicting results. We aimed to assess the benefits of levosimendan on VA-ECMO for time to successful ECMO weaning, using a pragmatic and rigorous definition of successful VA-ECMO weaning in patients with potential for cardiac function recovery.

View Article and Find Full Text PDF

Background: Fulminant myocarditis (FM) is a severe condition primarily triggered by viruses. Anti-RNA polymerase III autoantibodies (RNApol3) which are typically found in patients with severe systemic sclerosis, have been reported in patients with influenza-related FM. Our objective is to provide additional insight into RNApol3-associated FM.

View Article and Find Full Text PDF

Purpose: Onco-hematological (OH) patients face significant cardiovascular risks due to malignancy and drug toxicity. Data are limited on the characteristics and outcomes of OH patients with cardiogenic shock (CS) in intensive care units (ICUs).

Methods: This multicenter retrospective study included 214 OH patients with CS across 22 ICUs (2010-2021).

View Article and Find Full Text PDF

Background: Postcardiotomy cardiogenic shock (PCCS) in cardiac surgery is associated with a high rate of morbidity and mortality. Beside other therapeutic measures (e.g.

View Article and Find Full Text PDF

Purpose: The pathogenesis of life-threatening coronavirus disease 2019 (COVID-19) pneumonia in ICU patients can involve pre-existing auto-antibodies (auto-Abs) neutralizing type I interferons (IFNs). The impact of these auto-Abs on SARS-CoV-2 clearance in the lower respiratory tract (LRT) is unclear.

Methods: We performed a retrospective study in 99 ICU patients with COVID-19 pneumonia between March and May 2020.

View Article and Find Full Text PDF

Purpose: Fever is frequent after extracorporeal membrane oxygenation (ECMO) decannulation. We aimed to evaluate the incidence of post-decannulation fever and describe its causes.

Methods: Adult ECMO patients who were successfully weaned from ECMO were retrospectively included.

View Article and Find Full Text PDF
Article Synopsis
  • This study examines the effectiveness of switching patients from peripheral veno-arterial ECMO (pECMO) to central ECMO (cECMO) as a treatment strategy for refractory cardiogenic shock (rCS).
  • Out of 80 patients analyzed, only 38% were successfully bridged to recovery, heart transplantation, or a ventricle assist device, while the remaining 62% died during cECMO treatment.
  • Complications were common, with high rates of renal issues and bleeding, and the study found that myocardial infarction significantly increased the risk of in-hospital mortality.
View Article and Find Full Text PDF
Article Synopsis
  • Researchers conducted a 7-year study in France and Italy to investigate the best timing and methods for weaning patients from venovenous ECMO (VV ECMO) after severe ARDS.
  • The study analyzed 393 patients, comparing those who were weaned from controlled ventilation versus spontaneous breathing, but found no significant differences in their 90-day successful weaning rates.
  • The study concluded that factors like age and existing health issues had a greater impact on weaning success than the ventilation strategy used during ECMO, indicating a need for more research in this area.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on the incidence and outcomes of prosthetic valve thrombosis in patients who received peripheral veno-arterial extracorporeal membrane oxygenation (pVA-ECMO) after valve replacement surgery for postcardiotomy cardiogenic shock (PCCS).
  • It involved a retrospective analysis of 549 patients, with 152 having valve replacements, and found that 9 developed thrombosis, resulting in a 30-day thrombosis incidence of approximately 7.5%.
  • The findings suggest that using an intra-aortic balloon pump (IABP) in conjunction with pVA-ECMO significantly reduces the risk of valve thrombosis and is linked to lower hospital mortality rates.
View Article and Find Full Text PDF
Article Synopsis
  • Severe thrombotic antiphospholipid syndrome (APS) significantly affects critical organs and has not been thoroughly studied in ICU patients, particularly regarding hematological issues.
  • A retrospective study in France tracked 134 APS patients in ICUs, revealing high rates of anemia (95%) and thrombocytopenia (93%), with low platelet counts linked to increased mortality.
  • The findings highlight the importance of understanding the causes of thrombocytopenia in APS patients, as conditions like thrombotic microangiopathy (TMA), heparin-induced thrombocytopenia (HIT), and disseminated intravascular coagulation (DIC) are prevalent in this population.
View Article and Find Full Text PDF

Objective: Previous studies have provided evidence that the discontinuation of hydroxychloroquine (HCQ), and chloroquine (CQ), in patients with systemic lupus erythematosus (SLE) is associated with an increased risk of disease flares, with limited information on the level of disease activity at the time of HCQ/CQ discontinuation. Here we aimed to describe the risk of SLE flare after withdrawal of HCQ or CQ in patients with SLE in remission.

Methods: Case-control study (1:2) comparing the evolution of patients with SLE after HCQ/CQ withdrawal for antimalarial retinopathy (cases) with patients with SLE matched for sex, antimalarial treatment duration and age at SLE diagnosis, whose antimalarial treatment was continued throughout the entire follow-up period (controls).

View Article and Find Full Text PDF
Article Synopsis
  • High-risk pulmonary embolism (PE) patients can experience hemodynamic instability despite treatment; VA-ECMO is explored as a life-saving intervention, but pre-treatment with systemic thrombolysis poses risks of bleeding.
  • A study covering 72 patients assessed ECMO complications and survival rates, revealing similar 90-day survival rates and bleeding incidents between those treated with systemic thrombolysis and those without.
  • Long-term quality of life for survivors was found to be acceptable, indicating that recent systemic thrombolysis shouldn't be deemed a contraindication for VA-ECMO in high-risk PE cases.
View Article and Find Full Text PDF
Article Synopsis
  • Right ventricular failure (RVF) is a critical issue leading to high mortality rates shortly after heart transplantation, and the study explores how isoproterenol (Iso) can help improve heart function in these patients.
  • A retrospective study over one year evaluated the hemodynamic effects of Iso in 25 patients with early RVF, comparing no Iso treatment to low and high doses of Iso.
  • Results showed that Iso significantly increased heart rate and cardiac index, indicating improved heart function, while its effects on pulmonary pressures were minimal, highlighting its potential as a beneficial treatment for RVF post-heart transplant.
View Article and Find Full Text PDF
Article Synopsis
  • The study examines the recurrence of ventilator-associated pneumonia (VAP) in patients with severe COVID-19 treated with ECMO, highlighting how common VAP recurrence is among this group.
  • Out of 210 patients who developed initial VAP, 82% experienced a recurrence, typically within 10 days, predominantly caused by Enterobacteriaceae and Pseudomonas aeruginosa.
  • The duration of antibiotic treatment for the first episode (short course <8 days vs. prolonged course ≥8 days) did not significantly impact the likelihood of VAP recurrence.
View Article and Find Full Text PDF

Purpose Of The Review: Antiphospholipid syndrome (APS) is a rare systemic autoimmune disorder that can escalate into a 'thrombotic storm' called the catastrophic antiphospholipid syndrome (CAPS), frequently requiring ICU admission for multiple organ failure. This review aims to offer insight and recent evidence on critically-ill APS patients.

Recent Findings: The CAPS classification criteria define this condition as the involvement of at least three organs/systems/tissues within less than a week, caused by small vessel thrombosis, in patients with elevated antiphospholipid antibodies levels.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how extracorporeal membrane oxygenation (ECMO) affects blood levels of the antibiotic combination ceftazidime/avibactam, as altered drug levels can lead to treatment failures.
  • A retrospective analysis of 14 ECMO patients showed that while most had adequate ceftazidime levels, 39% had insufficient avibactam levels, particularly in patients with increased renal clearance.
  • The findings indicate that normal dosing of ceftazidime/avibactam is generally effective in ECMO patients, but that higher renal clearance can cause under dosing, highlighting the need for monitoring in these cases.
View Article and Find Full Text PDF